Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001628280-26-003418 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 26, 2026 |
| Document Date | Jan 22, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
5,646
Total Value
$41,294.84
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 22, 2026 | Exercise/Conversion | 1,882 | $3.79 | $7,132.40 | 147,237 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 22, 2026 | Sale | 1,882 | $18.15 | $34,162.44 | 145,355 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jan 22, 2026 | Exercise/Conversion | 1,882 | $0.00 | $0.00 | 65,462 | Direct | โ | View Details |